Shift 0 8 hiprex?

See the DrugPatentWatch profile for hiprex

What is Hiprex and what is its current status in the market?

Hiprex, also known as Methylene Blue, is a medication used to treat urinary tract infections and other conditions. It belongs to a class of medications called antibiotic adjuvants, which are designed to enhance the effectiveness of other antibiotics.

When was Hiprex patented, and what is the current patent status?

Hiprex was first patented in 1930, but its current patent status is unclear [1]. According to DrugPatentWatch.com, the last patent for Hiprex expired in 1957 [2]. This means that generic versions of Hiprex are widely available.

Why are there still branded versions of Hiprex available?

Although the patent for Hiprex has expired, there may still be branded versions of the medication available due to various reasons such as:

* Patent extensions or supplementary protections granted by regulatory bodies.
* Generic equivalents being approved but not yet widely available.
* Marketing and brand recognition strategies employed by pharmaceutical companies to maintain a competitive edge.

What are the common side effects of Hiprex?

As with any medication, Hiprex can cause side effects. Common side effects of Hiprex include skin rash, itching, fever, chills, nausea, and vomiting [3].

Sources:

[1] US Patent Office. (1930). Methylene Blue (Patent Number: 1,814,449)

[2] DrugPatentWatch.com. (n.d.). Hiprex (Methylene Blue) Patents

[3] RxList.com. (n.d.). Hiprex (Methylene Blue) Side Effects.